Researchers studied a TAAR1 variant found in an Indian family with schizophrenia and showed that a single amino acid change ...

Russia is facing a shortage of drugs which are used for the treatment of schizophrenia, psychosis, bipolar disorder, and ...

Panelists discuss how emerging therapies targeting new pathways may revolutionize schizophrenia management. Panelists discuss ...

CT-155 (Boehringer Ingelheim and Click Therapeutics), an investigational prescription digital therapeutic, was both safe and effective in reducing negative symptoms of schizophrenia in a new phase 3 ...

Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) on Tuesday announced a regulatory update following a pre-New Drug Application (pre-NDA) meeting with the U.S. Food and Drug Administration (FDA).

LB Pharmaceuticals aims to show that what is old can become new again with a lead drug candidate that’s a modified version of a decades-old schizophrenia medication from Sanofi. The strategy is ...

A large genetic study reveals shared genetic patterns linking schizophrenia with bone health, highlighting the need for ...

Scientists have discovered a surprising benefit of the acne drug doxycycline: it may lower the risk of schizophrenia. Teens prescribed the antibiotic were about one-third less likely to develop the ...